Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin.
Takahashi
H
H
1Department of Pharmacotherapy, Meiji Pharmaceutical University, Tokyo, Japan. harumit@my-phram.ac.jp
Echizen
H
H
D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D006470:Hemorrhage / Q000208:ethnology / Q000209:etiology / Q000235:genetics; D006801:Humans; D008657:Metabolic Clearance Rate / Q000235:genetics; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D014859:Warfarin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000925:Anticoagulants; D014859:Warfarin; D003577:Cytochrome P-450 Enzyme System